These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23436074)

  • 1. The emerging role of FDG PET/CT in rectal cancer management: is it time to use the technique for early prognostication?
    Tagliabue L
    Eur J Nucl Med Mol Imaging; 2013 May; 40(5):652-6. PubMed ID: 23436074
    [No Abstract]   [Full Text] [Related]  

  • 2. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation.
    Huh JW; Min JJ; Lee JH; Kim HR; Kim YJ
    Am J Clin Oncol; 2012 Aug; 35(4):340-4. PubMed ID: 21422901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prediction of response by ¹⁸F-FDG PET/CT during preoperative therapy in locally advanced rectal cancer: a systematic review.
    Maffione AM; Chondrogiannis S; Capirci C; Galeotti F; Fornasiero A; Crepaldi G; Grassetto G; Rampin L; Marzola MC; Rubello D
    Eur J Surg Oncol; 2014 Oct; 40(10):1186-94. PubMed ID: 25060221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Textural Parameters of Tumor Heterogeneity in ¹⁸F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer.
    Bundschuh RA; Dinges J; Neumann L; Seyfried M; Zsótér N; Papp L; Rosenberg R; Becker K; Astner ST; Henninger M; Herrmann K; Ziegler SI; Schwaiger M; Essler M
    J Nucl Med; 2014 Jun; 55(6):891-7. PubMed ID: 24752672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implications of initial FDG-PET/CT in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Lee SJ; Kim JG; Lee SW; Chae YS; Kang BW; Lee YJ; Park JS; Choi GS
    Cancer Chemother Pharmacol; 2013 May; 71(5):1201-7. PubMed ID: 23420438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New application of dual point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer.
    Yoon HJ; Kim SK; Kim TS; Im HJ; Lee ES; Kim HC; Park JW; Chang HJ; Choi HS; Kim DY; Oh JH
    Clin Nucl Med; 2013 Jan; 38(1):7-12. PubMed ID: 23242038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does baseline [18F] FDG-PET/CT correlate with tumor staging, response after neoadjuvant chemoradiotherapy, and prognosis in patients with rectal cancer?
    Deantonio L; Caroli A; Puta E; Ferrante D; Apicella F; Turri L; Sacchetti G; Brambilla M; Krengli M
    Radiat Oncol; 2018 Oct; 13(1):211. PubMed ID: 30359275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of 18-FDG-PET/MRI to assess pathological complete response following neoadjuvant radiochemotherapy in locally advanced rectal cancer. A prospective preliminary study.
    Ferri V; Vicente Lopez E; Quijano Collazo Y; Caruso R; Duran Gimenez Rico H; Ielpo B; Diaz Reques E; Fabra Cabrera I; Malavè Cardozo L; Isernia R; Pinna E; Plaza Hernandezv C; Garcerant M; Garcia Cañamaques L; Perez Dueñas V
    Acta Oncol; 2019 Sep; 58(9):1246-1249. PubMed ID: 31144557
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver metabolic activity changes over time with neoadjuvant therapy in locally advanced rectal cancer.
    Demir Y; Sürücü E; Şengöz T; Koç M; Kaya GÇ
    Nucl Med Commun; 2016 Feb; 37(2):116-21. PubMed ID: 26440564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When and why to use FDG PET/CT in locally advanced rectal cancer: two scenarios.
    Maffione AM; Galeotti F; Capirci C; Colletti PM; Rubello D
    Clin Nucl Med; 2014 Jun; 39(6):528-30. PubMed ID: 24806605
    [No Abstract]   [Full Text] [Related]  

  • 11. Colorectal cancer: prognostic role of 18F-FDG-PET/CT.
    Grassetto G; Capirci C; Marzola MC; Rampin L; Chondrogiannis S; Musto A; Crepaldi G; Minicozzi AM; Massaro A; Rubello D
    Abdom Imaging; 2012 Aug; 37(4):575-9. PubMed ID: 21847638
    [No Abstract]   [Full Text] [Related]  

  • 12. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
    Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR
    J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal timing for assessment of tumor response to neoadjuvant chemoradiation in patients with rectal cancer: do all patients benefit from waiting longer than 6 weeks?
    Perez RO; Habr-Gama A; São Julião GP; Gama-Rodrigues J; Sousa AH; Campos FG; Imperiale AR; Lynn PB; Proscurshim I; Nahas SC; Ono CR; Buchpiguel CA
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1159-65. PubMed ID: 22580120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of sequential 18(F) -FDG PET/CT in predicting tumour response after preoperative chemoradiation for rectal cancer.
    Sun W; Xu J; Hu W; Zhang Z; Shen W
    Colorectal Dis; 2013 May; 15(5):e231-8. PubMed ID: 23384167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Ono CR; Lynn P; Bailão Aguilar P; Nahas SC; Gama-Rodrigues J; Buchpiguel CA
    Colorectal Dis; 2013 Jun; 15(6):674-82. PubMed ID: 23374979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of 18F-FDG PET/CT for assessing the response to neoadjuvant therapy in locally advanced rectal cancer.
    Murcia Duréndez MJ; Frutos Esteban L; Luján J; Frutos MD; Valero G; Navarro Fernández JL; Mohamed Salem L; Ruiz Merino G; Claver Valderas MA
    Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):91-7. PubMed ID: 23081822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment.
    Hunter CJ; Garant A; Vuong T; Artho G; Lisbona R; Tekkis P; Abulafi M; Brown G
    Ann Surg Oncol; 2012 Apr; 19(4):1199-205. PubMed ID: 21913017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-FDG PET/MRI for Rectal Cancer TNM Restaging After Preoperative Chemoradiotherapy: Initial Experience.
    Crimì F; Spolverato G; Lacognata C; Garieri M; Cecchin D; Urso ED; Zucchetta P; Pucciarelli S; Pomerri F
    Dis Colon Rectum; 2020 Mar; 63(3):310-318. PubMed ID: 31842163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG-PET assessment of rectal cancer response to neoadjuvant chemoradiotherapy is not associated with long-term prognosis: a prospective evaluation.
    Ruby JA; Leibold T; Akhurst TJ; Shia J; Saltz LB; Mazumdar M; Riedel ER; Larson SM; Guillem JG
    Dis Colon Rectum; 2012 Apr; 55(4):378-86. PubMed ID: 22426260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F-18 FDG PET/CT in rectal carcinoma: where are we now?
    Grassetto G; Marzola MC; Minicozzi A; Al-Nahhas A; Rubello D
    Clin Nucl Med; 2011 Oct; 36(10):884-8. PubMed ID: 21892038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.